Literature DB >> 3189423

Minimal-change glomerulopathy of adulthood.

S M Korbet1, M M Schwartz, E J Lewis.   

Abstract

We describe 40 adults with idiopathic minimal-change glomerulopathy. They consisted of 27 females and 13 males, mean age 40.7 +/- (SD) 19.8 years (range 15-78 years). Twenty patients were less than 40 years of age at presentation. They presented with significantly (p less than 0.05) lower serum creatinine (0.9 +/- 0.2 vs. 1.3 +/- 0.5 mg/dl) and serum albumin (1.9 +/- 0.8 vs. 2.4 +/- 0.7 g/dl) levels than patients greater than 40 years. Only 7 patients (18%) presented with a decrease in renal function (serum creatinine greater than 1.3 mg/dl). All patients had nephrotic-range proteinuria at the time of presentation or biopsy. There was no significant difference in presenting proteinuria (8.7 +/- 5.7 g/24 h) or length of follow-up (mean 63.5, range 4-176 months) between the two age groups. Microscopic hematuria and hypertension were each present in 21% of the patients. Thirty-four patients received therapy with prednisone. A complete remission was obtained in 91% of the patients treated with prednisone. The response occurred within 16 weeks in 77% of the patients. The response to prednisone therapy was similar for patients less than 40 years when compared to those greater than 40 years, with a complete remission being obtained in 88 and 94%, respectively. The rate of response, however, differed significantly with 73% of patients less than 40 years versus 32% of patients greater than 40 years achieving a complete remission by 8 weeks. Twenty patients initially responding to prednisone therapy (64.5%) relapsed. A relapse occurred within 3 months of attaining a complete remission in 70% of the patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3189423     DOI: 10.1159/000167603

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  20 in total

1.  The characteristics of relapse in adult-onset minimal-change nephrotic syndrome.

Authors:  Takashi Takei; Minako Koike; Koichi Suzuki; Satsuki Shirota; Mitsuyo Itabashi; Shigeru Ohtsubo; Hidekazu Sugiura; Keiko Suzuki; Chiari Kojima; Masaki Takahashi; Jun Ino; Tetsuya Ogawa; Keiko Uchida; Ken Tsuchiya; Wako Yumura; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2007-09-28       Impact factor: 2.801

2.  Management of Adult Minimal Change Disease.

Authors:  Stephen M Korbet; William L Whittier
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-05       Impact factor: 8.237

3.  The Evolving Role of Rituximab in Adult Minimal Change Glomerulopathy.

Authors:  Landon C Brown; Meghan A Jobson; Fernanda Payan Schober; Emily H Chang; Ronald J Falk; Patrick H Nachman; William F Pendergraft
Journal:  Am J Nephrol       Date:  2017-03-18       Impact factor: 3.754

4.  Age and prediction of remission and relapse of proteinuria and corticosteroid-related adverse events in adult-onset minimal-change disease: a retrospective cohort study.

Authors:  Maki Shinzawa; Ryohei Yamamoto; Yasuyuki Nagasawa; Susumu Oseto; Daisuke Mori; Kodo Tomida; Terumasa Hayashi; Masaaki Izumi; Megumu Fukunaga; Atsushi Yamauchi; Yoshiharu Tsubakihara; Hiromi Rakugi; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2013-03-20       Impact factor: 2.801

5.  Adult-onset minimal change disease: the significance of histological chronic changes for clinical presentation and outcome.

Authors:  Gabriel Stefan; Ruxandra Busuioc; Simona Stancu; Madalina Hoinoiu; Adrian Zugravu; Nicoleta Petre; Gabriel Mircescu
Journal:  Clin Exp Nephrol       Date:  2020-10-22       Impact factor: 2.801

6.  Relapse of minimal change disease following infection with the 2009 pandemic influenza (H1N1) virus.

Authors:  Seo Rin Kim; Soo Bong Lee; Il Young Kim; Dong Won Lee; Harin Rhee; Eun Young Seong; Sang Heon Song; Ihm Soo Kwak
Journal:  Clin Exp Nephrol       Date:  2011-11-25       Impact factor: 2.801

7.  Amelioration of the adverse effects of prednisolone by rituximab treatment in adults with steroid-dependent minimal-change nephrotic syndrome.

Authors:  Yoei Miyabe; Takashi Takei; Yuko Iwabuchi; Takahito Moriyama; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2015-07-03       Impact factor: 2.801

8.  Comparison of methylprednisolone plus prednisolone with prednisolone alone as initial treatment in adult-onset minimal change disease: a retrospective cohort study.

Authors:  Maki Shinzawa; Ryohei Yamamoto; Yasuyuki Nagasawa; Susumu Oseto; Daisuke Mori; Kodo Tomida; Terumasa Hayashi; Masaaki Izumi; Megumu Fukunaga; Atsushi Yamauchi; Yoshiharu Tsubakihara; Yoshitaka Isaka
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237

9.  IgA nephropathy with minimal change disease.

Authors:  Leal C Herlitz; Andrew S Bomback; Michael B Stokes; Jai Radhakrishnan; Vivette D D'Agati; Glen S Markowitz
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237

10.  Proteinuria predicts relapse in adolescent and adult minimal change disease.

Authors:  Cristiane Bitencourt Dias; Cilene Carlos Pinheiro; Vanessa dos Santos Silva; Rodrigo Hagemann; Rui Toledo Barros; Viktoria Woronik
Journal:  Clinics (Sao Paulo)       Date:  2012-11       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.